Literature DB >> 21912409

Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.

Valerie Voon, Jeffrey W Dalley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21912409     DOI： 10.1038/nrneurol.2011.139

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Lateral prefrontal cortex and self-control in intertemporal choice.

Authors:  Bernd Figner; Daria Knoch; Eric J Johnson; Amy R Krosch; Sarah H Lisanby; Ernst Fehr; Elke U Weber
Journal:  Nat Neurosci       Date:  2010-03-28       Impact factor: 24.884

2.  Subthalamic nucleus lesions increase impulsive action and decrease impulsive choice - mediation by enhanced incentive motivation?

Authors:  Jason M Uslaner; Terry E Robinson
Journal:  Eur J Neurosci       Date:  2006-10       Impact factor: 3.386

3.  Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and D-cycloserine.

Authors:  Filip S van den Bergh; Emilie Bloemarts; Lucianne Groenink; Berend Olivier; Ronald S Oosting
Journal:  Pharmacol Biochem Behav       Date:  2007-01-17       Impact factor: 3.533

4.  Activation of dorsal raphe serotonin neurons underlies waiting for delayed rewards.

Authors:  Katsuhiko Miyazaki; Kayoko W Miyazaki; Kenji Doya
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

5.  Intertemporal choice in Parkinson's disease.

Authors:  Maria Milenkova; Bahram Mohammadi; Katja Kollewe; Christoph Schrader; Anja Fellbrich; Matthias Wittfoth; Reinhard Dengler; Thomas F Münte
Journal:  Mov Disord       Date:  2011-05-12       Impact factor: 10.338

6.  Impulse control disorders in Parkinson disease: a multicenter case--control study.

Authors:  Valerie Voon; Mandy Sohr; Anthony E Lang; Marc N Potenza; Andrew D Siderowf; Jacqueline Whetteckey; Daniel Weintraub; Glen R Wunderlich; Mark Stacy
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

7.  Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors.

Authors:  Charlotte R Housden; Sean S O'Sullivan; Eileen M Joyce; Andrew J Lees; Jonathan P Roiser
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

8.  Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Authors:  Valerie Voon; Brady Reynolds; Christina Brezing; Cecile Gallea; Meliha Skaljic; Vindhya Ekanayake; Hubert Fernandez; Marc N Potenza; Raymond J Dolan; Mark Hallett
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

9.  Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

Authors:  Thilo van Eimeren; Bénédicte Ballanger; Giovanna Pellecchia; Janis M Miyasaki; Anthony E Lang; Antonio P Strafella
Journal:  Neuropsychopharmacology       Date:  2009-09-09       Impact factor: 7.853

10.  Influence of reward delays on responses of dopamine neurons.

Authors:  Shunsuke Kobayashi; Wolfram Schultz
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167
  10 in total
  13 in total

1.  Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Authors:  Angela M Lee; Erik B Oleson; Leontien Diergaarde; Joseph F Cheer; Tommy Pattij
Journal:  Basal Ganglia       Date:  2012-07-28

2.  Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Authors:  Nicola J Ray; Janis M Miyasaki; Mateusz Zurowski; Ji Hyun Ko; Sang Soo Cho; Giovanna Pellecchia; Francesca Antonelli; Sylvain Houle; Anthony E Lang; Antonio P Strafella
Journal:  Neurobiol Dis       Date:  2012-07-03       Impact factor: 5.996

Review 3.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

4.  Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease.

Authors:  Emilie Favre; Bénédicte Ballanger; Stéphane Thobois; Emmanuel Broussolle; Philippe Boulinguez
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

5.  Impulsivity and rapid decision-making for reward.

Authors:  Stephanie Burnett Heyes; Robert J Adam; Maren Urner; Leslie van der Leer; Bahador Bahrami; Paul M Bays; Masud Husain
Journal:  Front Psychol       Date:  2012-05-22

6.  Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: a case report.

Authors:  Mette Buhl Callesen; K V Hansen; A Gjedde; J Linnet; A Møller
Journal:  Front Behav Neurosci       Date:  2013-07-29       Impact factor: 3.558

7.  Oscillatory activity in the medial prefrontal cortex and nucleus accumbens correlates with impulsivity and reward outcome.

Authors:  Nicholas A Donnelly; Tahl Holtzman; P Dylan Rich; Alejo J Nevado-Holgado; Anushka B P Fernando; Gert Van Dijck; Tobias Holzhammer; Oliver Paul; Patrick Ruther; Ole Paulsen; Trevor W Robbins; Jeffrey W Dalley
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

8.  Dopaminergic function and intertemporal choice.

Authors:  J Joutsa; V Voon; J Johansson; S Niemelä; J Bergman; V Kaasinen
Journal:  Transl Psychiatry       Date:  2015-01-06       Impact factor: 6.222

9.  Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?

Authors:  Jean-Luc Houeto; Robin Magnard; Jeffrey W Dalley; David Belin; Sebastien Carnicella
Journal:  Front Psychiatry       Date:  2016-05-30       Impact factor: 4.157

10.  White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Impulse Control Disorders.

Authors:  Mahtab Mojtahed Zadeh; Amir Ashraf-Ganjouei; Farzaneh Ghazi Sherbaf; Maryam Haghshomar; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.